Journal article
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Abstract
BACKGROUND: The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.
METHODS: In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or …
Authors
Bosch J; Gerstein HC; Dagenais GR; Díaz R; Dyal L; Jung H; Maggiono AP; Probstfield J; Ramachandran A; Riddle MC
Journal
The New England Journal of Medicine, Vol. 367, No. 4, pp. 309–318
Publisher
Massachusetts Medical Society
Publication Date
July 26, 2012
DOI
10.1056/nejmoa1203859
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedCardiovascular DiseasesCholesterolDiabetes Mellitus, Type 2Double-Blind MethodDrug Therapy, CombinationFatty Acids, Omega-3FemaleFollow-Up StudiesGlucose IntoleranceHumansHypoglycemic AgentsIncidenceInsulin GlargineInsulin, Long-ActingIntention to Treat AnalysisMaleMiddle AgedProportional Hazards ModelsTreatment FailureTriglycerides